ApoE, the strongest genetic risk factor for late-onset AD [147], influences numerous processes, including amyloid aggregation and clearance, tau-induced neurodegeneration, glucose metabolism, and synaptic function [148]. This evidence concerns the gene MAPT and Alzheimer disease.